Inogen, Inc. ( INGN) - Stock Earnings
INGN Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Nov. 4, 2026, midnight | — / — | — | — / — | — |
INGN Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | -7.1 million USD | 81.7 million USD |
| 2026Q1 | -8.3 million USD | 85.1 million USD |
| 2026Q2 | -3.9 million USD | 95.1 million USD |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
| 2027Q2 Est. | — | — |
INGN Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -102.4 million USD | 315.7 million USD |
| 2024 | -35.9 million USD | 335.7 million USD |
| 2025 | -22.7 million USD | 348.7 million USD |
| 2026 Est. | — | — |
INGN
Price: $6.15
52 week price:
Earnings Per Share: -0.89 USD
Exchange: NMS
Sector: Healthcare
Industry: Medical Devices
Country: United States
Volume: 86424
Ebitda: 11.8 millionMarket Capitalization: 161.6 million